A team led by Prof. Wuran Wei from West China Hospital of Sichuan University and Dr. Dechao Feng from the Division of Surgery and Interventional Science at University College London has systematically ...

Researchers from SRM Institute of Science and Technology, led by Dr. KN Aruljothi, have published a study in ExRNA ...

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality worldwide. Current treatment modalities are few or ...

K. O'Reilly et al., "mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt," Cancer Res, 66:1500—8, 2006. (Cited in 95 papers) It's known that rapamycin inhibits ...

Researchers sought to evaluate differences in ctDNA profiles, use of targeted treatments, and overall survival between Black and White patients with metastatic breast cancer.

Konstantinopoulos, MD, PhD, of the Dana-Farber Cancer Institute in Boston ... activated protein kinase], leading to inhibition of mTOR signalling, and indirectly by decreasing circulating insulin ...

mTOR has been shown to have a significant role in the signalling ... under development for Familial Adenomatous Polyposis and Non-Muscle Invasive Blader Cancer; tolimidone, under development for the ...

mTOR has been shown to have a significant role in the signalling ... CPRIT funding has advanced scientific and clinical knowledge and provided 7.4 million life-saving cancer prevention and early ...

Clinically, cancer is characterized by the uncontrollable division of cells, which can multiply and spread, making the condition life-threatening. Treatment strategies have evolved significantly, with ...